DYNAMO: a PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE‐REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA. (June 2017)

• Record Type: Journal Article
• Authors: Zinzani, P.; Wagner‐Johnston, N.; Miller, C.; Ardeshna, K.; Tertreault, S.; Assouline, S.; Mayer, J.; Passamonti, F.; Lunin, S.; Pettitt, A.; Nagy, Z.; Tournilhac, O.; Abou‐Nassar, K.; Crump, M.; Jacobsen, E.; De Vos, S.; Youssoufian, H.; Porter, J.; Prado, S.; Flinn, I.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 69
• Page End: 70
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2437_57
• Languages: English
• ISSNs: 0278-0232